GB0101437D0 - Novel Compounds - Google Patents

Novel Compounds

Info

Publication number
GB0101437D0
GB0101437D0 GB0101437A GB0101437A GB0101437D0 GB 0101437 D0 GB0101437 D0 GB 0101437D0 GB 0101437 A GB0101437 A GB 0101437A GB 0101437 A GB0101437 A GB 0101437A GB 0101437 D0 GB0101437 D0 GB 0101437D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0101437A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB0101437A priority Critical patent/GB0101437D0/en
Priority to DE60139429T priority patent/DE60139429D1/en
Priority to NZ520752A priority patent/NZ520752A/en
Priority to SK1177-2002A priority patent/SK287296B6/en
Priority to SI200130941T priority patent/SI1686119T1/en
Priority to ES06075890T priority patent/ES2330552T3/en
Priority to BRPI0108396-1A priority patent/BRPI0108396B1/en
Priority to AT01907522T priority patent/ATE333446T1/en
Priority to KR1020027010662A priority patent/KR100781425B1/en
Priority to EP06075890A priority patent/EP1686119B1/en
Priority to CZ2002-2768A priority patent/CZ304450B6/en
Priority to PCT/EP2001/001515 priority patent/WO2001060805A1/en
Priority to JP2001560190A priority patent/JP4095804B2/en
Priority to ES01907522T priority patent/ES2267714T3/en
Priority to DK06075890T priority patent/DK1686119T3/en
Priority to PT01907522T priority patent/PT1263740E/en
Priority to AU3546601A priority patent/AU3546601A/en
Priority to AU2001235466A priority patent/AU2001235466B2/en
Priority to DK01907522T priority patent/DK1263740T3/en
Priority to SI200130614T priority patent/SI1263740T1/en
Priority to PL357382A priority patent/PL209824B1/en
Priority to PT06075890T priority patent/PT1686119E/en
Priority to MXPA02008062A priority patent/MXPA02008062A/en
Priority to AT06075890T priority patent/ATE437862T1/en
Priority to EP01907522A priority patent/EP1263740B1/en
Priority to HU0204410A priority patent/HU229479B1/en
Priority to DE60121550T priority patent/DE60121550T2/en
Priority to UA2002097389A priority patent/UA73762C2/en
Priority to CA002400554A priority patent/CA2400554C/en
Priority to CNB01806521XA priority patent/CN1179952C/en
Priority to GCP20011178 priority patent/GC0000221A/en
Priority to MYPI20010671A priority patent/MY135732A/en
Priority to US09/782,930 priority patent/US20020103213A1/en
Priority to ARP010100659A priority patent/AR030190A1/en
Priority to CO01011957A priority patent/CO5271661A1/en
Priority to TW090103332A priority patent/TW550259B/en
Publication of GB0101437D0 publication Critical patent/GB0101437D0/en
Priority to NO20023828A priority patent/NO324691B1/en
Priority to IL151236A priority patent/IL151236A/en
Priority to BG107034A priority patent/BG66014B1/en
Priority to US10/357,238 priority patent/US6649619B1/en
Priority to HK03104052A priority patent/HK1053466A1/en
Priority to US10/694,561 priority patent/US7153861B2/en
Priority to CY20061101441T priority patent/CY1105649T1/en
Priority to US11/561,035 priority patent/US7470694B2/en
Priority to US11/561,926 priority patent/US7638520B2/en
Priority to IL181957A priority patent/IL181957A0/en
Priority to US12/349,086 priority patent/US7652019B2/en
Priority to US12/372,837 priority patent/US20090170877A1/en
Priority to CY20091101045T priority patent/CY1109484T1/en
Priority to US12/707,838 priority patent/US20100144765A1/en
Priority to US13/309,941 priority patent/US8871775B2/en
Priority to US14/522,870 priority patent/US9266841B2/en
Ceased legal-status Critical Current

Links

GB0101437A 2000-02-16 2001-01-19 Novel Compounds Ceased GB0101437D0 (en)

Priority Applications (52)

Application Number Priority Date Filing Date Title
GB0101437A GB0101437D0 (en) 2001-01-19 2001-01-19 Novel Compounds
DE60139429T DE60139429D1 (en) 2000-02-16 2001-02-13 Pyrimidine-5-onderivatives as LDL-PLA2 inhibitors
NZ520752A NZ520752A (en) 2000-02-16 2001-02-13 Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
SK1177-2002A SK287296B6 (en) 2000-02-16 2001-02-13 Pyrimidine-4-one derivatives, pharmaceutical compositions containing them and their use
SI200130941T SI1686119T1 (en) 2000-02-16 2001-02-13 Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
ES06075890T ES2330552T3 (en) 2000-02-16 2001-02-13 DERIVATIVES OF PYRIMIDIN-5-ONA AS INHIBITORS OF LDL-PLA2.
BRPI0108396-1A BRPI0108396B1 (en) 2000-02-16 2001-02-13 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
AT01907522T ATE333446T1 (en) 2000-02-16 2001-02-13 PYRIMIDINE-4-ONE DERIVATIVE AS LDL-PLA2 INHIBITOR
KR1020027010662A KR100781425B1 (en) 2000-02-16 2001-02-13 Pyrimidine-4-one Derivatives as LDL-PLA2 Inhibitors
EP06075890A EP1686119B1 (en) 2000-02-16 2001-02-13 Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
CZ2002-2768A CZ304450B6 (en) 2000-02-16 2001-02-13 Pyrimidine derivative
PCT/EP2001/001515 WO2001060805A1 (en) 2000-02-16 2001-02-13 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
JP2001560190A JP4095804B2 (en) 2000-02-16 2001-02-13 Pyrimidin-4-one derivatives as LDL-PLA2 inhibitors
ES01907522T ES2267714T3 (en) 2000-02-16 2001-02-13 DERIVATIVE OF PYRIMIDIN-4-ONA INHIBITOR OF LDL-PLA2.
DK06075890T DK1686119T3 (en) 2000-02-16 2001-02-13 Pyrimidin-5-one derivatives as LDL-PLA2 inhibitors
PT01907522T PT1263740E (en) 2000-02-16 2001-02-13 Pyrimidine-4-one derivative as ldl-pla2 inhibitor
AU3546601A AU3546601A (en) 2000-02-16 2001-02-13 Pyrimidine-4-one derivatives as LDL-PLA<sub>2</sub> inhibitors
AU2001235466A AU2001235466B2 (en) 2000-02-16 2001-02-13 Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
DK01907522T DK1263740T3 (en) 2000-02-16 2001-02-13 Pyrimidin-4-one derivative as LDL-PLA2 inhibitor
SI200130614T SI1263740T1 (en) 2000-02-16 2001-02-13 Pyrimidine-4-one derivative as ldl-pla2 inhibitor
PL357382A PL209824B1 (en) 2000-02-16 2001-02-13 Pyrimidine−4−one derivatives as ldl−pla2
PT06075890T PT1686119E (en) 2000-02-16 2001-02-13 Pyrimidine-5-one derivatives as ldl-pla2 inhibitors
MXPA02008062A MXPA02008062A (en) 2000-02-16 2001-02-13 Pyrimidine 4 one derivatives as ldl pla2.
AT06075890T ATE437862T1 (en) 2000-02-16 2001-02-13 PYRIMIDINE-5-ONE DERIVATIVES AS LDL-PLA2 INHIBITORS
EP01907522A EP1263740B1 (en) 2000-02-16 2001-02-13 Pyrimidine-4-one derivative as ldl-pla2 inhibitor
HU0204410A HU229479B1 (en) 2000-02-16 2001-02-13 Pyrimidine-4-one derivatives
DE60121550T DE60121550T2 (en) 2000-02-16 2001-02-13 Pyrimidin-4-one derivative as LDL-PLA2 inhibitor
UA2002097389A UA73762C2 (en) 2000-02-16 2001-02-13 Pirimidine compounds, a method for the preparation thereof, a pharmaceutical composition and use thereof
CA002400554A CA2400554C (en) 2000-02-16 2001-02-13 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
CNB01806521XA CN1179952C (en) 2000-02-16 2001-02-13 Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
GCP20011178 GC0000221A (en) 2000-02-16 2001-02-14 Pyrimidinone compounds, processes for their preparation, intermediates useful in their preparation, and pharmaceutical compositions containing them
MYPI20010671A MY135732A (en) 2000-02-16 2001-02-14 5,6-trimethylenepyrimidin - 4 - one compounds
US09/782,930 US20020103213A1 (en) 2000-02-16 2001-02-14 Novel compounds
ARP010100659A AR030190A1 (en) 2000-02-16 2001-02-14 A PYRIMIDINONE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, USE OF SUCH COMPOUND IN THE MANUFACTURE OF MEDICINES AND PROCEDURE TO PREPARE IT
CO01011957A CO5271661A1 (en) 2000-02-16 2001-02-15 PYRIMIDONES OF BIFENILO WITH ACTIVITY AGAINST ATEROSCLEROSIS
TW090103332A TW550259B (en) 2000-02-16 2001-02-15 Novel compounds
NO20023828A NO324691B1 (en) 2000-02-16 2002-08-13 Pyrimidin-4-one derivatives, pharmaceutical composition containing such a compound, and use of the compounds
IL151236A IL151236A (en) 2000-02-16 2002-08-13 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
BG107034A BG66014B1 (en) 2000-02-16 2002-08-26 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
US10/357,238 US6649619B1 (en) 2000-02-16 2003-02-03 Compounds
HK03104052A HK1053466A1 (en) 2000-02-16 2003-06-09 Pyrimidine-4-one derivative as ldl-pla2 inhibitor
US10/694,561 US7153861B2 (en) 2000-02-16 2003-10-27 5,6 -Trimethylenepyrimidin-4-one compounds
CY20061101441T CY1105649T1 (en) 2000-02-16 2006-10-06 PYRIMIDINE-4-ONE DERIVATIVE AS A LDL-PLA2 INHIBITOR
US11/561,035 US7470694B2 (en) 2000-02-16 2006-11-17 5,6-trimethylenepyrimidin-4-one compounds
US11/561,926 US7638520B2 (en) 2000-02-16 2006-11-21 Pyrimidine compounds
IL181957A IL181957A0 (en) 2000-02-16 2007-03-15 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
US12/349,086 US7652019B2 (en) 2000-02-16 2009-01-06 5,6-trimethylenepyrimidin-4-one compounds
US12/372,837 US20090170877A1 (en) 2000-02-16 2009-02-18 5,6-Trimethylenepyrimidin-4-one compounds
CY20091101045T CY1109484T1 (en) 2000-02-16 2009-10-12 PYRIMIDIN-5-ONE PRODUCTS AS LDL-PLA2 INHIBITORS
US12/707,838 US20100144765A1 (en) 2000-02-16 2010-02-18 5,6-trimethylenepyrimidin-4-one compounds
US13/309,941 US8871775B2 (en) 2000-02-16 2011-12-02 Compounds
US14/522,870 US9266841B2 (en) 2000-02-16 2014-10-24 Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0101437A GB0101437D0 (en) 2001-01-19 2001-01-19 Novel Compounds

Publications (1)

Publication Number Publication Date
GB0101437D0 true GB0101437D0 (en) 2001-03-07

Family

ID=9907133

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0101437A Ceased GB0101437D0 (en) 2000-02-16 2001-01-19 Novel Compounds

Country Status (1)

Country Link
GB (1) GB0101437D0 (en)

Similar Documents

Publication Publication Date Title
GB0105895D0 (en) Novel compounds
AU2002359165A8 (en) Novel compounds
GB0106586D0 (en) Novel compounds
GB0104259D0 (en) Novel compounds
GB0102470D0 (en) Novel compounds
GB0102713D0 (en) Novel compounds
GB0103866D0 (en) Novel compounds
GB0106613D0 (en) Novel compounds
GB0107659D0 (en) Novel compounds
GB0107388D0 (en) Novel compounds
GB0107116D0 (en) Novel compounds
GB0106157D0 (en) Novel compounds
GB0107391D0 (en) Novel compounds
GB0106584D0 (en) Novel compounds
GB0106451D0 (en) Novel compounds
GB0100181D0 (en) Novel compounds
GB0101437D0 (en) Novel Compounds
GB0106156D0 (en) Novel compounds
GB0106155D0 (en) Novel Compounds
GB0107626D0 (en) Novel compounds
GB0105634D0 (en) Novel compounds
GB0105234D0 (en) Novel compounds
GB0105095D0 (en) Novel compounds
GB0104970D0 (en) Novel compounds
GB0107631D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)